Tahta Mesut, Zengin Eyup C, Ozturk Tahir, Mete B Dirim, Gunal İzge, Sener Muhittin
Department of Orthopaedics and Traumatology, Ataturk Training and Research Hospital, Katip Celebi University, Izmir, Turkey.
Department of Radiology, Ataturk Training and Research Hospital, Katip Celebi University, Izmir, Turkey.
Plast Surg (Oakv). 2019 May;27(2):141-146. doi: 10.1177/2292550319828787. Epub 2019 Mar 13.
Treatment of Kienböck disease is still a clinical challenge. The treatment used in each instance is decided according to stage of the disease at presentation. Good clinical and radiological results could be obtained with partial capitate shortening osteotomy. However, mid-term results of this technique and its effect on lunate revascularization are not well known.
The aim of this study was to report our results of partial capitate shortening osteotomy in the treatment of stage II and IIIA Kienböck disease.
Ten patients were enrolled in the study with a mean age of 37.7 years old (standard deviation [SD] = 9.6). Patients were evaluated clinically in terms of range of motion, DASH and VAS scores, satisfaction with the outcome, and grip/tip/palmar/key pinch strength compared to the contralateral side. Radiological evaluation consisted of Lichtman staging on plain radiographs and lunate revascularization on magnetic resonance imaging (MRI) at both preoperative and postoperative evaluations.
The mean duration of follow-up was 55.2 (SD = 24) months. The mean DASH and VAS scores were 14.3 (SD = 6.7) and 1.5 (SD = 1.3), respectively. For patient satisfaction, the mean score was 3.6 (SD = 0.6). The Lichtman stage of 7 patients remained unchanged. Lunate revascularization was detected with MRI in 6 patients.
Although the number of patients in the study prevents more strict conclusions, our results are promising, and the technique presented offers minimally but observable lunate revascularization and high success rates in preventing the progression of the disease.
月骨无菌性坏死的治疗仍是一项临床挑战。每次治疗方案的选择取决于疾病初诊时的分期。部分头状骨缩短截骨术可取得良好的临床和影像学效果。然而,该技术的中期疗效及其对月骨血运重建的影响尚不清楚。
本研究旨在报告部分头状骨缩短截骨术治疗Ⅱ期和ⅢA期月骨无菌性坏死的结果。
本研究纳入10例患者,平均年龄37.7岁(标准差[SD]=9.6)。对患者进行临床评估,包括活动范围、DASH和VAS评分、对治疗结果的满意度,以及与对侧相比的握力/指尖捏力/掌捏力/钥匙捏力。影像学评估包括术前和术后通过X线平片进行Lichtman分期以及通过磁共振成像(MRI)评估月骨血运重建情况。
平均随访时间为55.2(SD=24)个月。平均DASH和VAS评分分别为14.3(SD=6.7)和1.5(SD=1.3)。患者满意度平均评分为3.6(SD=0.6)。7例患者的Lichtman分期未改变。6例患者通过MRI检测到月骨血运重建。
尽管本研究中的患者数量限制了得出更严格的结论,但我们的结果很有前景,所介绍的技术可实现最低限度但可观察到的月骨血运重建,并在预防疾病进展方面具有较高的成功率。